Harrow, Inc.

Harrow Inc. is a notable player in the healthcare and pharmaceutical sector, primarily focused on the development, production, and distribution of innovative medicines. The company's core competency is in ophthalmology, where it has established a reputation for delivering effective treatments for a range of eye conditions. Harrow Inc. not only pioneers in providing high-quality formulations but also commits to making these treatments affordable and accessible, aiming to address critical gaps in the market. Headquartered in the United States, Harrow Inc. operates a dynamic business model that includes both proprietary products and important generic formulations, catering to a diverse array of healthcare needs. Its significant role in the pharmaceutical industry is underscored by its impact on improving patient outcomes and its dedication to clinical excellence. By focusing on a vital area of healthcare, Harrow Inc. contributes to the overall enhancement of consumer quality of life and supports healthcare providers with essential, reliable products.